126 related articles for article (PubMed ID: 21821972)
1. Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats.
Kawasaki Y; Araki H; Suemaru K; Kitamura Y; Gomita Y; Sendo T
J Pharmacol Sci; 2011; 117(1):27-33. PubMed ID: 21821972
[TBL] [Abstract][Full Text] [Related]
2. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
Kawasaki Y; Jin C; Suemaru K; Kawasaki H; Shibata K; Choshi T; Hibino S; Gomita Y; Araki H
Br J Pharmacol; 2005 Jul; 145(6):751-7. PubMed ID: 15880144
[TBL] [Abstract][Full Text] [Related]
3. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
4. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats.
Kawasaki Y; Ishida S; Jin C; Kitamura Y; Kawasaki H; Gomita Y; Sendo T; Araki H
Eur J Pharmacol; 2011 Sep; 666(1-3):131-4. PubMed ID: 21635886
[TBL] [Abstract][Full Text] [Related]
5. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
[TBL] [Abstract][Full Text] [Related]
6. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
8. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats.
Araki H; Kawakami KY; Jin C; Suemaru K; Kitamura Y; Nagata M; Futagami K; Shibata K; Kawasaki H; Gomita Y
Psychopharmacology (Berl); 2004 Feb; 171(4):398-404. PubMed ID: 13680070
[TBL] [Abstract][Full Text] [Related]
9. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
10. The acute administration of the selective dopamine D(3) receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats.
Rice OV; Gardner EL; Heidbreder CA; Ashby CR
Synapse; 2012 Jan; 66(1):85-7. PubMed ID: 21905128
[TBL] [Abstract][Full Text] [Related]
11. Dorsal hippocampal NMDA receptor blockade impairs extinction of naloxone-precipitated conditioned place aversion in acute morphine-treated rats by suppressing ERK and CREB phosphorylation in the basolateral amygdala.
Wang WS; Chen ZG; Liu WT; Chi ZQ; He L; Liu JG
Br J Pharmacol; 2015 Jan; 172(2):482-91. PubMed ID: 24597568
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
13. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.
Souza AJ; Guimarães FS; Gomes FV
Behav Brain Res; 2023 Jul; 450():114504. PubMed ID: 37209879
[TBL] [Abstract][Full Text] [Related]
15. CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.
Wills KL; Vemuri K; Kalmar A; Lee A; Limebeer CL; Makriyannis A; Parker LA
Psychopharmacology (Berl); 2014 Nov; 231(22):4291-300. PubMed ID: 24770676
[TBL] [Abstract][Full Text] [Related]
16. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
Cui R; Suemaru K; Li B; Kohnomi S; Araki H
Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
[TBL] [Abstract][Full Text] [Related]
17. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
18. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
Motoshima S; Suemaru K; Kawasaki Y; Jin C; Kawasaki H; Gomita Y; Araki H
Eur J Pharmacol; 2005 Sep; 519(1-2):91-5. PubMed ID: 16098507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
